Canada-USA (CANUSA) Peritoneal Dialysis Study Group.Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes.J Am Soc Nephrol1996; 7: 198–207.
2.
ChurchillD.N., ThorpeK.E., NolphK.D., OreopoulosD.G., PageD., KeshaviahP.R., for the CANUSA Peritoneal Dialysis Study Group. CAPD patient and technique survivals are worse with increased membrane permeability.Perit Dial Int1996; 16: (Suppl 2): S21.
WuC.H., HuangC.C., HuangJ.Y., WuM.S., LeuM.L.High flux peritoneal membrane is a risk factor in survival of CAPD treatment. In: KhannaR., ed. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Publications, 1996; 12: 105–9.
5.
LoW.K., BrendolanA., ProwantB.F.Changes in the peritoneal equilibration test in selected chronic peritoneal dialysis patients.J Am Soc Nephrol1994; 4: 1466–77.
6.
NolphK.D., MooreH.L., ProwantB.Continuous ambulatory peritoneal dialysis with a high flux membrane.ASAIO J1993; 39: 904–9.
7.
BlakeP.G., FlowerdewG., BlakeR.M., OreopoulosD.G.Serum albumin in patients of continuous ambulatory peritoneal dialysis: predictors and correlations with outcomes.J Am Soc Nephrol1993; 3: 1501–7.
8.
United States Renal Data System.USRDS 1996 Annual Report.Bethesda, MD: National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases. 1996(April): 69–84.